Celgene, stricken by setbacks, bids a quiet goodbye to dealmaking czar Golumbeski

Celgene's business development head George Golumbeski left the company in April, at a time when the Big Biotech is struggling to recover from a series of setbacks and stumbles over the last…
Read the full story: FiercePharma: Pharma